choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Ampyra

Ampyra Newsletter
  • Optum Rx Ends Reauthorization for Many Chronic Disease Drugs 19 Mar 2025 18:04 GMT

    … chronic treatment Long-term drug effectiveness … , Orkambi, Pulmozyme, Alyftrek Multiple sclerosis drugs: Mavenclad, Plegridy, Lemtrada, … Ampyra, Gilenya, Tecfidera, Tysabri, Zeposia, Tascenso ODT, Briumvi Migraine drugs … services in Medicare Advantage plans. …

  • Epilepsy Drugs Market to Worth USD 10.9 Billion by 2032, Driven by Innovation & Rising Prevalence – SNS Insider 13 Feb 2025 11:15 GMT

    … to treatments,  advanced epilepsy medications are … , Invega) • Teva Pharmaceuticals - (Copaxone, Lamotrigine) … Acorda Therapeutics - (Ampyra, Inbrija) Regional Analysis … Drugs Market by Product 8. Epilepsy Drugs Market by Drugs Type 9. Epilepsy Drugs

  • Spinal Cord Injury Treatment Market to Reach USD 11.28 Billion by 2032, Driven by Technological Advancements 31 Jan 2025 12:19 GMT

    Medicine Research) • Acorda Therapeutics - (Ampyra for … medications from SCI patients, particularly the administration of advanced pharmaceuticals … . Food and Drug Administration (FDA) has approved … Cord Injury Treatment Market by Treatment Type 8 …

  • FTC says top three PBMs made $7.3 billion from marked up drug prices 16 Jan 2025 01:59 GMT

    … commercial health plans and Medicare Part D prescription drug plans managed by … Drug Codes, which include the generic versions of Ampyra (used to treat multiple sclerosis … data on commercial and Medicare Part D prescription drug plan (PDP) enrollees, …

  • New FTC Report: PBMs Mark Up Specialty Generic Drugs 14 Jan 2025 22:57 GMT

    … commercial health plans and Medicare Part D prescription drug plans managed by … generic versions of Ampyra, which is used to treat multiple sclerosis; Gleevec, which … provide to Formulary Watch, the Pharmaceutical Care Management Association said: “It …

  • FTC Releases Second Interim Staff Report on Prescription Drug Middlemen 14 Jan 2025 23:18 GMT

    … a wide range of lifesaving drugs, including medications to treat heart disease … commercial health plans and Medicare Part D prescription drug plans managed by … Drug Codes, which include the generic versions of: Ampyra (used to treat multiple sclerosis

  • FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs 15 Jan 2025 18:11 GMT

    … revenue from markups on essential medications used to treat cancer, … practices that may inflate drug costs and harm independent pharmacies … generic drugs, including critical medications such as Ampyra, Gleevec, Sensipar, and Myfortic. These drugs accounted …

  • Acorda Joins Growing Group of Biotechs Filing for Bankruptcy, Divests Assets to Merz 03 Apr 2024 12:43 GMT

    … asset purchase agreement with German biotech Merz Therapeutics, which has … , including its FDA-approved drugs Inbrija (levodopa inhalation powder), Ampyra (dalfampiridine) and … supply of our medications to people with multiple sclerosis and Parkinson’s …

  • Acorda loses Nasdaq listing to cap biotech’s end 16 Apr 2024 16:27 GMT

    … twilight zone. The biotech’s closure date is … drugs for neurological disorders. Inbrija (levodopa inhalation powder) and Ampyra … ability of patients with multiple sclerosis. According to GlobalData’s … the parent company of Pharmaceutical Technology. Access the …

  • Acorda seeks buyer as neurological drug sales fall 05 Apr 2024 00:30 GMT

    … of the year. Merz Pharmaceuticals, of Frankfurt, German, … founded in 1995 by medical doctor Ron Cohen. It is … developed medicines that treat Parkinson’s disease and multiple sclerosis. Ampyra, also … drug was undergoing clinical trials. The U.S. Food and Drug

Satisfied with the content?

Continue to create your account.